New Edge Advisors, LLC Alkermes Plc. Transaction History
New Edge Advisors, LLC
- $11.2 Billion
- Q1 2024
A detailed history of New Edge Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 13,492 shares of ALKS stock, worth $326,236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,492
Previous 15,427
12.54%
Holding current value
$326,236
Previous $427,000
14.52%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$705 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$487 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$360 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$218 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$201 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.97B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...